Exelixis Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Exelixis Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Alameda
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: January
Ticker symbol: EXEL
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0000939767
EIN: 04-3257395
Wikidata ID: Q5419989

Board of directors

Follow this board

Alan M. Garber · Director
Since 2023
Bob Oliver · Director
Since 2023
Carl B. Feldbaum · Director
Since 2023
David Edward Johnson · Director
Since 2023
George Poste · Director
Since 2023
Jack L. Wyszomierski · Director
Since 2023
Jacqueline Wright · Director
Since 2023
Julie Smith · Director
Since 2023
Maria C. Freire · Director
Since 2023
Mary C. Beckerle · Director
Since 2024
Michael Morrissey · Director · President and CEO
Since 2023
Stelios Papadopoulos · Director
Since 2023
Sue Gail Eckhardt · Director
Since 2024
Tomas J. Heyman · Director
Since 2023

Chief executives

Michael Morrissey · President and CEO

Dates unknown

Director election results

Annual meeting of May 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Jack L. Wyszomierski

97.8%

Board connections

11 of this board's directors also sit on 16 other boards. 12 are in the same sector.

Shared director Other board Same sector

Alexandria Real Estate Equities Inc.
via Maria C. Freire
Becton Dickinson and Company Same sector
via Jacqueline Wright
Biogen Inc. Same sector
via Maria C. Freire
Caris Life Sciences Inc. Same sector
via George Poste
Huntsman Corporation
via Mary C. Beckerle
Invivyd Inc. Same sector
via Tomas J. Heyman
Johnson & Johnson Same sector
via Mary C. Beckerle
Legend Biotech Corporation Same sector
via Tomas J. Heyman
Liquidia Corporation Same sector
via David Edward Johnson
Ovid Therapeutics Inc. Same sector
via Stelios Papadopoulos
SiteOne Landscape Supply Inc.
via Jack L. Wyszomierski
Stoke Therapeutics Inc. Same sector
via Julie Smith
Vera Therapeutics Inc. Same sector
via Michael Morrissey
Vertex Pharmaceuticals Incorporated Same sector
via Alan M. Garber
Xilio Therapeutics Inc. Same sector
via Tomas J. Heyman
nVent Electric plc
via Jacqueline Wright

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $1,187,180; 1 purchase by 1 insider
Sold, last 12 months: $39,153,653; 29 sales by 12 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 10, 2026	Mary C. Beckerle Director	Open-market sale	−9,812	$53.66	$526,512
Jun 1, 2026	Jack L. Wyszomierski Director	Open-market sale	−3,925	$50.55	$198,409
Jun 1, 2026	Sue Gail Eckhardt Director	Open-market sale	−9,812	$50.14	$491,974
May 27, 2026	Stelios Papadopoulos Director	Grant or award	+8,367	—	—
May 27, 2026	Tomas J. Heyman Director	Grant or award	+8,367	—	—
May 27, 2026	Sue Gail Eckhardt Director	Grant or award	+8,367	—	—
May 27, 2026	Julie Smith Director	Grant or award	+8,367	—	—
May 27, 2026	Maria C. Freire Director	Grant or award	+8,367	—	—
May 27, 2026	Mary C. Beckerle Director	Grant or award	+8,367	—	—
May 27, 2026	Bob Oliver Director	Grant or award	+8,367	—	—
May 27, 2026	Jack L. Wyszomierski Director	Grant or award	+8,367	—	—
May 27, 2026	George Poste Director	Grant or award	+8,367	—	—
May 26, 2026	Aftab Dana Officer (EVP, Research and Development)	Open-market sale	−43,451	$50.35	$2,187,758
May 20, 2026	Haley Patrick J. Officer (EVP, Commercial)	Open-market sale	−32,110	$49.81	$1,599,399
May 18, 2026	Michael Morrissey Director, Officer (President and CEO)	Gift	−124,047	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Exelixis Inc.

Who is the CEO of Exelixis Inc.?

Michael Morrissey is Exelixis Inc.'s President and CEO.

How many directors are on Exelixis Inc.'s board?

Exelixis Inc.'s board has 14 directors: Alan M. Garber, Bob Oliver, Carl B. Feldbaum, David Edward Johnson, George Poste, Jack L. Wyszomierski, Jacqueline Wright, Julie Smith, Maria C. Freire, Mary C. Beckerle and 4 others.

Are Exelixis Inc. insiders buying or selling shares?

Over the last 12 months, Exelixis Inc. insiders bought $1.2 million of shares in 1 purchase and sold $39.2 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Exelixis Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="exelixis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.